Description
Super Tadarise (Tadalafil + Dapoxetine) 20 mg + 60 mg
Super Tadarise is a combination product identified by its listed active ingredients, tadalafil and dapoxetine. Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor used for erectile dysfunction, and dapoxetine is a short-acting selective serotonin reuptake inhibitor (SSRI) used for premature ejaculation in some jurisdictions. This combination is intended to address erectile dysfunction and premature ejaculation together, but the trade name itself is not an official regulatory product name in the sources reviewed.
Active Ingredient and Medicine Class
Tadalafil is a PDE5 inhibitor. Official prescribing information describes it as a medicine for erectile dysfunction and, in some products, benign prostatic hyperplasia.
Dapoxetine is an SSRI designed for on-demand use in premature ejaculation. EMA identifies it as a selective serotonin re-uptake inhibitor.
Established Medical Uses
Tadalafil is established for erectile dysfunction, and in some approved products also for benign prostatic hyperplasia or both conditions together.
Dapoxetine is established for premature ejaculation in men in jurisdictions where it is approved. EMA states it is used to treat premature ejaculation in men aged 18 to 64 years.
How It Works
Tadalafil helps relax blood vessels in the penis by inhibiting PDE5, which supports blood flow during sexual stimulation.
Dapoxetine increases serotonin signalling by blocking serotonin reuptake. Reviews and EMA material note that this can delay ejaculation and improve ejaculatory control.
Important Safety Information
Tadalafil products have important contraindications and interaction risks, especially with nitrates and other medicines that lower blood pressure. Official labeling also warns about precautions in patients with cardiovascular disease and with certain interacting medicines.
Dapoxetine has clinically significant interaction risks with serotonergic medicines and other drugs that may increase the chance of serotonin-related adverse effects or fainting. EMA notes that patients should not start at the higher-strength tablet and should only be switched if lower-strength treatment is insufficient and tolerated.
Because this is a fixed-dose combination, the safety profile depends on both ingredients and on the patient’s other medicines and underlying conditions.
Possible Side Effects
Tadalafil is commonly associated with headache, dyspepsia, back pain, myalgia, nasal congestion and flushing in official labeling. More serious but less common reactions can include priapism and sudden vision or hearing problems.
Dapoxetine is commonly associated with nausea, dizziness, somnolence, headache, diarrhoea and insomnia. Reviews also describe syncope as an important safety concern.
Scientific Evidence
Peer-reviewed reviews and meta-analyses show that tadalafil improves erectile function compared with placebo, and dapoxetine improves intravaginal ejaculatory latency time and patient-reported control measures in men with premature ejaculation. The dapoxetine literature also reports a generally acceptable safety profile, although adverse effects are more frequent than with placebo. Evidence specifically for the combined fixed-dose product is more limited than for the individual components.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed — Tadalafil tablets, prescribing information: official label
- European Medicines Agency — Priligy referral: official document
- Salonia et al. — “Efficacy and safety of dapoxetine in treatment of premature ejaculation: an evidence-based review” — International Journal of Clinical Practice (2016): PubMed
